BML Investment Partners, L.P. 13D and 13G filings for Talaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-27 2:19 pm Unchanged | 2023-04-17 | 13G | TALARIS THERAPEUTICS INC TALS | BML Investment Partners, L.P. | 218,919 5.200% | 0 (Unchanged) | Filing |
| 2023-04-27 10:55 am Purchase | 2023-04-17 | 13G | TALARIS THERAPEUTICS INC TALS | BML Investment Partners, L.P. | 218,919 5.200% | 218,919 (New Position) | Filing |